Navigation Links
Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah
Date:7/16/2008

ers (BRMs). Argyll Biotechnologies, LLC has initiated the process for regulatory approval of SF-1019 in several countries and preparations for clinical trials are underway in both the U.S. and Europe. Research suggests that SF-1019 has the potential to affect a number of clinical conditions including complications from Diabetic Mellitus such as Diabetic Neuropathy (DN) and diabetic ulcers (DU), auto-immune disorders such as Multiple Sclerosis (MS) and neurological disorders such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS). (For more information on Immunosyn and SF-1019 go to http://www.immunosyn.com).

The above news release contains forward-looking statements. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and are subject to a wide range of business risks, external factors and uncertainties. Actual results may differ materially from those indicated by such forward-looking statements. For additional information, please consult the Company's most recent public filings and Annual Report on Form 10-K for its most recent fiscal year. The Company assumes no obligation to update the information contained in this press release, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Immunosyn Corporation Names Stephen Ferrone as CEO
2. Immunosyn Corporation to Begin Trading
3. Equity Research Firm Issued Unauthorized Report and Press Release on Immunosyn Corporation Today
4. Immunosyn Announces the Successful Completion of First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
5. Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... March 02, 2015 To ... and manage their practices compliantly and profitably, ... all-inclusive solution. The interoperability between a ... a medical practice management system is necessary ... financial sustainability. A referral management and development ...
(Date:3/1/2015)... Security Life Insurance Company of America, ... the addition of stand-alone individual vision insurance to ... today, complete with two plan options. , The ... Vision Care network encompassing a strong presence of ... PrimeStar Select Vision plan will use the prominent ...
(Date:3/1/2015)... As residents and business owners ... Burns and Carita Weaver, believe in supporting local ... the Southlake Chamber of Commerce, Carroll Independent School ... launched a website for Southlake mayoral candidate Laura ... tool for Hill’s campaign, the website combines images, ...
(Date:3/1/2015)... Women’s Excellence is pleased to announce the ... their website. There are over 75 terms and phrases available ... , “This gives our patients a better understanding of what our ... may not understand. With this resource, our patients are able ... find terms and phrases that they may not remember or comprehend ...
(Date:3/1/2015)... 01, 2015 Women’s Excellence now ... Bladder (OAB) symptoms, such as a strong need to urinate ... of medication (anticholinergic) does not work well enough or cannot ... takes another approach to targeting the source of OAB, the ... nerves and bladder muscle, blocking the signals that trigger OAB. ...
Breaking Medicine News(10 mins):Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Security Life Insurance Company Launches Individual Vision Insurance Product 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2
... and Nurse Training Needed, Experts Say, PHILADELPHIA, ... Supply, an independent group of healthcare leaders based ... White House to convene a,special conference to address ... to healthcare services cannot be maintained, let alone,expanded, ...
... Pa., March 26 WPCS International,Incorporated (Nasdaq: ... engineering services,for specialty communication systems and wireless ... has been awarded approximately,$12 million in new ... be completed for The University of,Connecticut, The ...
... Uses of Gourmetceuticals, ... and PPL-240(TM), BIG HORN, Wyo., March 26 ... and scientifically validated,ingredients for use in foods and ... GLPH-1, an immune booster, and,PPL-240, an antioxidant, will ...
... Mich., March 26 The next phase of,Michigan,s ... be lead by,CJPS Enterprises, LLC (http://www.CJPS-Enterprises.com ). ... Corporation to create a,network of researchers, entrepreneurs and ... project. The project was created through the $2,billion ...
... ... http://www.cryocath.com , ... leader in cryotherapy products to treat cardiac,arrhythmias, today announced the ... product for the treatment of,paroxysmal atrial fibrillation (PAF), is a ...
... Results from the third annual Alzheimers Foundation of ... suggest that Alzheimers disease care is a family affair. ... children under 21 who also care for an aging ... say their children are assisting with caregiving responsibilities that ...
Cached Medicine News:Health News:Council Calls on White House to Convene Conference on Physician and Nurse Supply 2Health News:WPCS Announces $12 Million in New Projects 2Health News:Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008 2Health News:CJPS Enterprises to Expand Efforts of 21st Century Jobs Fund Life Sciences Pipeline 2Health News:CryoCath Introduces Arctic Front in Australia 2Health News:CryoCath Introduces Arctic Front in Australia 3Health News:New Alzheimer's disease survey reveals children of sandwich caregivers assist with loved ones' care 2Health News:New Alzheimer's disease survey reveals children of sandwich caregivers assist with loved ones' care 3
(Date:3/1/2015)... DALLAS , March 2, 2015 ... Industry 2015 Market Research Report of 178 pages ... online business intelligence library. The 2015 ... industry is a professional and deep research report ... analysis, the report introduces Angiographic X-ray System basic ...
(Date:3/1/2015)... 1, 2015 /CNW Telbec/ -   Ergoresearch Ltd (TSXV: ... and known under the « Équilibre, orthèses et ... quarter Ended on December 31, 2014. All dollar amounts ... Revenues for the second quarter of fiscal ... $ 4 095 112 decreasing by 8,8 % compared to revenues of ...
(Date:3/1/2015)... , March 1, 2015  An innovative interventional ... migraine sufferers sustained relief of their headaches, according ... of Interventional Radiology ,s Annual Scientific Meeting ... State University New York Empire State College in ... sphenopalatine ganglion (SPG) blocks to give patients enough ...
Breaking Medicine Technology:Global Angiographic X-ray System Industry Research Report 2Global Angiographic X-ray System Industry Research Report 3Global Angiographic X-ray System Industry Research Report 4Global Angiographic X-ray System Industry Research Report 5Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 3Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 4Image-guided treatment shown to break the migraine cycle 2Image-guided treatment shown to break the migraine cycle 3Image-guided treatment shown to break the migraine cycle 4
... be needed to achieve desired anticoagulant effect in some ... October 8 , SILVER SPRING, Md., Oct. 1 ... health care professionals to a change in heparin manufacturing ... common blood-clotting drug. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , ...
... Accuray Incorporated (Nasdaq: ARAY ), a global leader ... results from a study of early stage prostate cancer ... erectile function was preserved in 81 percent of patients ... of erectile function preservation at two years for other ...
Cached Medicine Technology:FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency 2FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 4
... The Infinity Uric Acid single liquid ... the convenience of single liquid stability ... operator error and provide quick result ... the Infinity Uric Acid reagent provides ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
... Creatinine single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... reagent provides a long shelf life ...
... practice by seeing more patients per day. Utilizing ... turn a 14-18 patients per day practice into ... automated test sequences, youll perform accurate refractions in ... learn; making it easy to delegate tasks to ...
Medicine Products: